B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes - Trial NCT02588898
Access comprehensive clinical trial information for NCT02588898 through Pure Global AI's free database. This phase not specified trial is sponsored by Universität des Saarlandes and is currently Completed. The study focuses on Diabetes Complications. Target enrollment is 212 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Universität des Saarlandes
Timeline & Enrollment
N/A
Sep 01, 2009
Jan 01, 2011
Primary Outcome
Red blood cell cobalamin levels,Polyneuropathy grade estimated using a score including a combination of data from questionnaire and electrophysiology investigations
Summary
This case-control study investigated B-vitamin and homocysteine in relation to the presence
 or the absence of type 2 diabetes and clinical signs of polyneuropathy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02588898
Device Trial